High-Titer Self-Propagating Capsidless Chikungunya Virus Generated in Vero Cells as a Strategy for Alphavirus Vaccine Development-Reference-Cited by-同舟云学术

High-Titer Self-Propagating Capsidless Chikungunya Virus Generated in Vero Cells as a Strategy for Alphavirus Vaccine Development

Published:2022-03-23 Issue:6 Volume:96 Page:
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:J Virol

Author:

Zhang Ya-Nan¹²,Zhang Zhe-Rui¹²,Li Na¹²,Pei Xin-Ru³,Li Xiao-Dan⁴,Deng Cheng-Lin¹,Ye Han-Qing¹²,Zhang Bo¹²³^ORCID

Affiliation:

1. Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China

2. University of Chinese Academy of Sciences, Beijing, China

3. University of Science and Technology of China, School of Life Science, Hefei, Anhui, China

4. Hunan Normal University, School of Medicine, Changsha, China

Abstract

Chikungunya virus (CHIKV) is one of important emerging alphaviruses. Currently, there are no licensed vaccines against CHIKV infection.

Funder

MOST | National Key Research and Development Program of China

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/jvi.01480-21

Reference29 articles.

1. Biology and pathogenesis of chikungunya virus

2. Chikungunya fever: CNS infection and pathologies of a re-emerging arbovirus

3. Neurocognitive Outcome of Children Exposed to Perinatal Mother-to-Child Chikungunya Virus Infection: The CHIMERE Cohort Study on Reunion Island

4. Perinatal Outcomes in Vertically Infected Neonates During a Chikungunya Outbreak on the Island of Curaçao

5. Neonatal encephalitis due to Chikungunya vertical transmission: First report in Brazil

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational design of self-amplifying virus-like vesicles with Ebola virus glycoprotein as vaccines;Molecular Therapy;2024-08

2. An overview of anti-Chikungunya antibody response in natural infection and vaccine-mediated immunity, including anti-CHIKV vaccine candidates and monoclonal antibodies targeting diverse epitopes on the viral envelope;The Microbe;2023-12

3. Application of self-amplifying mRNA technology in the development of infectious disease vaccines;Chinese Science Bulletin;2023-10-01

4. The evolution of chikungunya virus circulating in Indonesia: Sequence analysis of the orf2 gene encoding the viral structural proteins;International Microbiology;2023-02-11

5. Chikungunya patient transcriptional signatures faithfully recapitulated in a C57BL/6J mouse model;Frontiers in Immunology;2022-12-12